Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentCell Culture

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1501263

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1501263

3D Cell Cultures Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 220 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

Fairfield Market Research's latest report on the 3D Cell Cultures market highlights an impressive growth trajectory. The market, valued at US$ 1.66 Billion in 2024, is expected to expand at a CAGR of 7.6% from 2024 to 2031, reaching US$ 2.78 Billion by 2031.

????? ???????? ?? ?????? ???? ???? ?? ???? ?? ?????? ??????? ??? ???? ?? ????

The global 3D cell cultures market recorded a historic CAGR of 7.4% from 2018 to 2023. The market is expected to grow significantly over the next decade due to the increasing adoption of 3D cell culture techniques. These techniques involve creating an artificial environment where cells can grow and be studied in a three-dimensional structure that closely resembles tissue or organ environments.

??????? ?? ?????? ??????

Increasing Focus on Oncology Research

3D cell cultures are widely employed due to their practical and novel capabilities, especially in oncology research. They provide a more accurate model of tissues, making them essential for cell-based assays used in cancer research. The ability to simulate pathological and physiological settings dramatically decreases development time in the preclinical phase. Increased focus on oncology research has provided significant traction to the market.

Support from Research Initiatives

Initiatives like the National Cancer Institute (NCI) Genomic Data Commons (GDC), Cancer Moonshot, and the National Clinical Trials Network (NCTN) have bolstered research efforts in cancer, facilitating the growth of the 3D cell cultures market. These initiatives underscore the importance of advanced research techniques and funding support, driving market expansion.

?????? ?????? ??? ?? ???? ????????: ????? ?????????? ??? ????????? ?? ?????? ???

Shift Away from Animal Testing

The market for 3D cell cultures is anticipated to grow as these cultures replace animal testing in laboratories. The Humane Society International reports that over 115 million animals are used annually in research. Regulations and guidelines that limit animal use and encourage 3D cell culture adoption are gaining traction, providing growth opportunities.

Support from Government and Non-Profit Organizations

Organizations like the National Toxicology Program, the Environmental Protection Agency, and the National Institutes of Health's ToxCast initiative are working to replace animal testing with 3D cell cultures. These efforts, coupled with rising awareness, present significant growth prospects for the 3D cell cultures market.

??????? ??????????? ?????? ??????

Lack of Skilled Professionals and Investments

The shortage of skilled professionals in R&D and insufficient investment in laboratory equipment are key challenges. Handling 3D cell culture requires specialized training, which can be costly and impede market growth. Additionally, the lack of awareness about training programs further limits the availability of skilled individuals.

Scaffold Challenges in 3D Cell Culture

Scaffolds play a crucial role in 3D cell culture, providing physical support for cell growth. However, synthesizing scaffolds with desirable mechanical properties and porosity remains a challenge. This limitation could hinder the market's expansion despite the advantages of 3D cell culture over traditional 2D models.

???????? ????????

United States: Leading the Market

The U.S. is set to account for around 38.4% share of the global 3D cell cultures market in 2024. The country has heavily invested in R&D and technological advancements over the past decade. The presence of major patent applicants and foreign funding agencies has further boosted demand for 3D cell cultures in the U.S.

Germany: Rising Awareness and Technological Adoption

Germany is expected to hold around 6.8% share of the global market in 2024. The country has made significant efforts to increase public awareness of 3D cell cultures through training programs and seminars. Conferences promoting the adoption of this technology, along with government support for biological research, are driving market growth in Germany.

?????? ????????? ?? ??? ?? ???? ???????? ??????

Innovative Treatments and Biosimilars

The development of innovative treatments and the availability of biosimilars are driving market growth. Since the introduction of the first biopharmaceutical drug, Humulin, in 1982, the market has seen rapid expansion. The FDA approved 48 new biopharmaceutical drugs in 2019 alone. The demand for biosimilar medicines produced using 3D cell culture is expected to transform the biopharmaceutical industry, providing significant market acceleration over the forecast period.

Technological Advancements and R&D Investments

Continued technological advancements and increased investments in R&D are crucial for the market's growth. The presence of foreign funding agencies and the region's growing infrastructure have both contributed to the rise in demand for 3D cell cultures.

Key Market Players:

  • Merck KGaA (Sigma-Aldrich Corporation)
  • Thermo Fisher Scientific, Inc.
  • Corning Incorporated.
  • Becton.Dickinson and Company
  • 3D Biotek LLC.
  • Lonza Group.
  • InSphero AG.
  • Synthecon, Inc
  • Nanofiber Solutions, Inc
  • Greiner Group A
  • REPROCELL

Market Segments Covered in 3D Cell Cultures Market Analysis:

Product:

  • Scaffold Free 3D Cell Culture
  • Scaffold Based 3D Cell Culture
    • oHydrogel based 3D cell culture
    • oPolymeric Hard Material Based 3D cell Culture

Application:

  • Drug Discovery
  • Tissue Regeneration & Regenerative Medicines
  • Cancer Research
  • Stem Cell Technology
  • Others

End User:

  • Biotechnology and Pharmaceuticals Industries
  • Academic Research Institutes
  • Hospital Laboratories
  • Contract Research Organization

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global 3D Cell Cultures Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global 3D Cell Cultures Market Outlook, 2018 - 2031

  • 3.1. Global 3D Cell Cultures Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Scaffold Free 3D Cell Culture
      • 3.1.1.2. Scaffold Based 3D Cell Culture
        • 3.1.1.2.1. Hydrogel based 3D cell culture
        • 3.1.1.2.2. Polymeric Hard Material Based 3D cell Culture
  • 3.2. Global 3D Cell Cultures Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Drug Discovery
      • 3.2.1.2. Tissue Regeneration & Regenerative Medicines
      • 3.2.1.3. Cancer Research
      • 3.2.1.4. Stem Cell Technology
      • 3.2.1.5. Others
  • 3.3. Global 3D Cell Cultures Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Biotechnology and Pharmaceuticals Industries
      • 3.3.1.2. Academic Research Institutes
      • 3.3.1.3. Hospital Laboratories
      • 3.3.1.4. Contract Research Organization
  • 3.4. Global 3D Cell Cultures Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America 3D Cell Cultures Market Outlook, 2018 - 2031

  • 4.1. North America 3D Cell Cultures Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Scaffold Free 3D Cell Culture
      • 4.1.1.2. Scaffold Based 3D Cell Culture
        • 4.1.1.2.1. Hydrogel based 3D cell culture
        • 4.1.1.2.2. Polymeric Hard Material Based 3D cell Culture
  • 4.2. North America 3D Cell Cultures Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Drug Discovery
      • 4.2.1.2. Tissue Regeneration & Regenerative Medicines
      • 4.2.1.3. Cancer Research
      • 4.2.1.4. Stem Cell Technology
      • 4.2.1.5. Others
  • 4.3. North America 3D Cell Cultures Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Biotechnology and Pharmaceuticals Industries
      • 4.3.1.2. Academic Research Institutes
      • 4.3.1.3. Hospital Laboratories
    • 4.3.2. Contract Research Organization
  • 4.4. North America 3D Cell Cultures Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.2. Market Attractiveness Analysis

5. Europe 3D Cell Cultures Market Outlook, 2018 - 2031

  • 5.1. Europe 3D Cell Cultures Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Scaffold Free 3D Cell Culture
      • 5.1.1.2. Scaffold Based 3D Cell Culture
        • 5.1.1.2.1. Hydrogel based 3D cell culture
        • 5.1.1.2.2. Polymeric Hard Material Based 3D cell Culture
  • 5.2. Europe 3D Cell Cultures Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Drug Discovery
      • 5.2.1.2. Tissue Regeneration & Regenerative Medicines
      • 5.2.1.3. Cancer Research
      • 5.2.1.4. Stem Cell Technology
      • 5.2.1.5. Others
  • 5.3. Europe 3D Cell Cultures Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Biotechnology and Pharmaceuticals Industries
      • 5.3.1.2. Academic Research Institutes
      • 5.3.1.3. Hospital Laboratories
      • 5.3.1.4. Contract Research Organization
    • 5.3.2. Market Attractiveness Analysis
  • 5.4. Europe 3D Cell Cultures Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.2. Market Attractiveness Analysis

6. Asia Pacific 3D Cell Cultures Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific 3D Cell Cultures Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Scaffold Free 3D Cell Culture
      • 6.1.1.2. Scaffold Based 3D Cell Culture
        • 6.1.1.2.1. Hydrogel based 3D cell culture
        • 6.1.1.2.2. Polymeric Hard Material Based 3D cell Culture
  • 6.2. Asia Pacific 3D Cell Cultures Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Drug Discovery
      • 6.2.1.2. Tissue Regeneration & Regenerative Medicines
      • 6.2.1.3. Cancer Research
      • 6.2.1.4. Stem Cell Technology
      • 6.2.1.5. Others
  • 6.3. Asia Pacific 3D Cell Cultures Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Biotechnology and Pharmaceuticals Industries
      • 6.3.1.2. Academic Research Institutes
      • 6.3.1.3. Hospital Laboratories
      • 6.3.1.4. Contract Research Organization
    • 6.3.2. Market Attractiveness Analysis
  • 6.4. Asia Pacific 3D Cell Cultures Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.2. Market Attractiveness Analysis

7. Latin America 3D Cell Cultures Market Outlook, 2018 - 2031

  • 7.1. Latin America 3D Cell Cultures Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Scaffold Free 3D Cell Culture
      • 7.1.1.2. Scaffold Based 3D Cell Culture
        • 7.1.1.2.1. Hydrogel based 3D cell culture
        • 7.1.1.2.2. Polymeric Hard Material Based 3D cell Culture
  • 7.2. Latin America 3D Cell Cultures Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Drug Discovery
      • 7.2.1.2. Tissue Regeneration & Regenerative Medicines
      • 7.2.1.3. Cancer Research
      • 7.2.1.4. Stem Cell Technology
      • 7.2.1.5. Others
  • 7.3. Latin America 3D Cell Cultures Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Biotechnology and Pharmaceuticals Industries
      • 7.3.1.2. Academic Research Institutes
      • 7.3.1.3. Hospital Laboratories
      • 7.3.1.4. Contract Research Organization
    • 7.3.2. Market Attractiveness Analysis
  • 7.4. Latin America 3D Cell Cultures Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.2. Market Attractiveness Analysis

8. Middle East & Africa 3D Cell Cultures Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa 3D Cell Cultures Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Scaffold Free 3D Cell Culture
      • 8.1.1.2. Scaffold Based 3D Cell Culture
        • 8.1.1.2.1. Hydrogel based 3D cell culture
        • 8.1.1.2.2. Polymeric Hard Material Based 3D cell Culture
  • 8.2. Middle East & Africa 3D Cell Cultures Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Drug Discovery
      • 8.2.1.2. Tissue Regeneration & Regenerative Medicines
      • 8.2.1.3. Cancer Research
      • 8.2.1.4. Stem Cell Technology
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa 3D Cell Cultures Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Biotechnology and Pharmaceuticals Industries
      • 8.3.1.2. Academic Research Institutes
      • 8.3.1.3. Hospital Laboratories
      • 8.3.1.4. Contract Research Organization
    • 8.3.2. Market Attractiveness Analysis
  • 8.4. Middle East & Africa 3D Cell Cultures Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa 3D Cell Cultures Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa 3D Cell Cultures Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa 3D Cell Cultures Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.2. Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product vs By Application Heat map
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Merck KGaA (Sigma-Aldrich Corporation)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Thermo Fisher Scientific, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Corning Incorporated.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Becton.Dickinson and Company
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. 3D Biotek LLC.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Lonza Group.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. InSphero AG.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Synthecon, Inc
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Nanofiber Solutions, Inc
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Greiner Group A
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!